These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1622185)

  • 1. Variation in the pharmacokinetics of gentamicin and tobramycin in patients with pleural effusions and hypoalbuminemia.
    Etzel JV; Nafziger AN; Bertino JS
    Antimicrob Agents Chemother; 1992 Mar; 36(3):679-81. PubMed ID: 1622185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of body weight on aminoglycoside pharmacokinetics in patients with hypoalbuminemia.
    Kale-Pradhan PB; Buckler V; Bush PW
    Am J Health Syst Pharm; 1997 Oct; 54(19):2201-3. PubMed ID: 9331441
    [No Abstract]   [Full Text] [Related]  

  • 3. Gentamicin, tobramycin and netilmicin pharmacokinetics in plasma and pleural fluid.
    Limthongkul S; Poshyachinda M; Charoenlap P; Nuchprayoon C
    J Med Assoc Thai; 1988 Oct; 71(10):541-7. PubMed ID: 3249161
    [No Abstract]   [Full Text] [Related]  

  • 4. Gentamicin and tobramycin pharmacokinetics in pediatric bone marrow transplant patients.
    Jacobson PA; West NJ; Price J; Hutchinson RJ
    Ann Pharmacother; 1997 Oct; 31(10):1127-31. PubMed ID: 9337435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetics of aminoglycosides in critically ill trauma patients on once-daily regimens.
    Barletta JF; Johnson SB; Nix DE; Nix LC; Erstad BL
    J Trauma; 2000 Nov; 49(5):869-72. PubMed ID: 11086778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a microcomputer program (OPT) for parameter optimisation in clinical pharmacokinetics: gentamicin and tobramycin.
    Zantvoort FA; Wagenvoort JH; Derkx FH; Michel MF
    Br J Clin Pharmacol; 1987 Oct; 24(4):511-8. PubMed ID: 3689631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective comparison of traditional and pharmacokinetic aminoglycoside dosing methods.
    Franson TR; Quebbeman EJ; Whipple J; Thomson R; Bubrick J; Rosenberger SL; Ausman RK
    Crit Care Med; 1988 Sep; 16(9):840-3. PubMed ID: 3402229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoalbuminemia as a cause of pleural effusions.
    Eid AA; Keddissi JI; Kinasewitz GT
    Chest; 1999 Apr; 115(4):1066-9. PubMed ID: 10208209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suboptimal aminoglycoside dosing in critically ill patients.
    Rea RS; Capitano B; Bies R; Bigos KL; Smith R; Lee H
    Ther Drug Monit; 2008 Dec; 30(6):674-81. PubMed ID: 19057371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aminoglycosides in intermittent hemodialysis: pharmacokinetics with individual dosing.
    Dager WE; King JH
    Ann Pharmacother; 2006 Jan; 40(1):9-14. PubMed ID: 16332944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of estimating individual pharmacokinetic data for aminoglycoside therapy in seriously ill patients.
    Denaro CP; Ravenscroft PJ
    Aust N Z J Med; 1987 Oct; 17(5):526-32. PubMed ID: 3446165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of tobramycin and gentamicin in abusers of intravenous drugs.
    King CH; Creger RJ; Ellner JJ
    Antimicrob Agents Chemother; 1985 Mar; 27(3):285-90. PubMed ID: 3994344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum level-adjusted dosage of once-daily aminoglycoside therapy in critical illness: results of a prospective study].
    Reimann IR; Meier-Hellmann A; Pfeifer R; Traut T; Schilling A; Stein G; Reinhart K; Hoffmann A
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 May; 34(5):288-95. PubMed ID: 10372218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of a 3 mg/kg body weight loading dose of gentamicin or tobramycin in critically ill patients.
    Chelluri L; Warren J; Jastremski MS
    Chest; 1989 Jun; 95(6):1295-7. PubMed ID: 2721269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodialysis elimination rates and clearance of gentamicin and tobramycin.
    Matzke GR; Halstenson CE; Keane WF
    Antimicrob Agents Chemother; 1984 Jan; 25(1):128-30. PubMed ID: 6703676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An approach to forecast aminoglycoside-related nephrotoxicity from routinely collected clinical data.
    Kubota K; Suganuma T; Sasaki T; Ishizaki T
    Ther Drug Monit; 1988; 10(4):410-20. PubMed ID: 3201525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A controlled investigation of the pharmacokinetics of gentamicin and tobramycin in obese subjects.
    Schwartz SN; Pazin GJ; Lyon JA; Ho M; Pasculle AW
    J Infect Dis; 1978 Oct; 138(4):499-505. PubMed ID: 712111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aminoglycoside pharmacokinetics: dosage requirements and nephrotoxicity in trauma patients.
    Townsend PL; Fink MP; Stein KL; Murphy SG
    Crit Care Med; 1989 Feb; 17(2):154-7. PubMed ID: 2914447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in aminoglycoside volume of distribution in patients below ideal body weight.
    Tointon MM; Job ML; Peltier TT; Murphy JE; Ward ES
    Clin Pharm; 1987 Feb; 6(2):160-2. PubMed ID: 3665369
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of multiple courses of therapy on aminoglycoside clearance in adult patients with cystic fibrosis.
    Alghanem S; Paterson I; Touw DJ; Thomson AH
    J Antimicrob Chemother; 2013 Jun; 68(6):1338-47. PubMed ID: 23435691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.